Healy James

Healy James is listed in filings as Director at Y-mAbs Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 18, 2025, including 17 public disclosures. Recent filings connect the profile to Y-mAbs Therapeutics, Inc. (YMAB), Rapport Therapeutics, Inc. Common Stock (RAPP), Bolt Biotherapeutics, Inc. (BOLT), and BioAge Labs, Inc. (BIOA). The current snapshot covers public activity from Jun 13, 2024 to Sep 18, 2025. Reported amounts are shown as $174.7K to $113.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.